InflaRx Ownership (IFRX)

USA |NASDAQ |USD |ADR

Inflarx Ownership Highlights

Inflarx (NASDAQ:IFRX) is owned by 25.65% institutional shareholders and by 14.89% insiders. The rest is owned by the public.

The largest institutional owner of Inflarx is "Suvretta Capital Management, LLC", owning 7.43% of the company's total share outstanding.

The largest mutual fund owner of Inflarx is "Biotech Growth Ord", owning 2.41% of the company's total share outstanding.

Institutional Owners of Inflarx

The top 10 institutional shareholders of Inflarx together own 10.01M shares, representing 22.65% of Inflarx's total shares outstanding.

The table below contains a list of the top institutional shareholders of IFRX.

Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
Suvretta Capital Management, LLC 3.29M 7.43% 0.15% - -
Great Point Partners LLC 2.20M 4.98% 1.37% - -
Orbimed Advisors, LLC 1.06M 2.41% 0.03% - -
Morgan Stanley - Brokerage Accounts 751.29K 1.70% 0.00% 30.32K 4.20%
Ikarian Capital, LLC 666.60K 1.51% 0.16% -33.15K -4.74%
Dafna Capital Management LLC 600.00K 1.36% 0.37% - -
LAURION CAPITAL MANAGEMENT LP 500.00K 1.13% 0.01% - -
Kingdon Capital Management LLC 400.00K 0.91% 0.14% - -
FNY Investment Advisers, LLC 343.00K 0.78% 0.41% -7.00K -2.00%
Bank Julius Baer & Co. Ltd, Zurich 197.64K 0.45% 0.00% 197.64K -

Top Mutual Funds Holding Inflarx (IFRX)

The table below contains a list of the top mutual funds holding IFRX.

Owner Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
Biotech Growth Ord 1.06M 2.41% 0.38% - -
Intl Small Cap (ACWI ex-US) Equity 49.80K 0.11% 0.23% 49.80K -
International SmallCap Equity 25.80K 0.06% 0.19% 25.80K -
ETFMG Treatments Testing and Adv ETF 16.13K 0.04% 0.06% - -
Fidelity® NASDAQ Composite Index® 12.01K 0.03% 0.00% - -
Pharus SICAV Dynamic Allc MV7 A EUR Acc 6.96K 0.02% 0.14% 6.96K -
WEALTHGATE Biotech Aggressive Fund I 5.57K 0.01% 0.22% - -

Inflarx Ownership: A Close Look

Inflarx's Largest Institutional Shareholders

The largest institutional shareholders of Inflarx are "Suvretta Capital Management, LLC", "Great Point Partners LLC" and "Orbimed Advisors, LLC". Those three own together 14.82% of IFRX's total shares outstanding.

1. Suvretta Capital Management, LLC

The company owns 3.29M shares of Inflarx, representing 7.43% of IFRX's total share outstanding. Using the last stock closing price of $2.86, Suvretta Capital Management, LLC's current total stake in Inflarx is worth $9.40M.

2. Great Point Partners LLC

The company owns 2.20M shares of Inflarx, representing 4.98% of IFRX's total share outstanding. Using the last stock closing price of $2.86, Great Point Partners LLC's current total stake in Inflarx is worth $6.29M.

3. Orbimed Advisors, LLC

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and healthcare services. The company's team contains over 100 distinguished scientific, medical, investment and other professionals manages over $17 billion across public and private company investments worldwide. OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.

The company owns 1.06M shares of Inflarx, representing 2.41% of IFRX's total share outstanding. Using the last stock closing price of $2.86, Orbimed Advisors, LLC's current total stake in Inflarx is worth $3.04M.

Inflarx's Largest Mutual Fund Holders

The largest mutual fund holders of Inflarx are "Biotech Growth Ord", "Intl Small Cap (ACWI ex-US) Equity" and "International SmallCap Equity". Together these mutual funds hold 2.58% of Inflarx's total share outstanding.

"Biotech Growth Ord" holds 1.06M shares, representing 2.41% of Inflarx's total shares outstanding.

"Intl Small Cap (ACWI ex-US) Equity" holds 49.80K shares, representing 0.11% of Inflarx's total shares outstanding.

"International SmallCap Equity" holds 25.80K shares, representing 0.06% of Inflarx's total shares outstanding.